Related Experiment Video
Updated: Feb 16, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Metformin inhibits HaCaT cell viability via the miR-21/PTEN/Akt signaling pathway
1Hypertension Center of Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100006, P.R. China.
Abstract:
Substantial preclinical evidence has indicated out a direct anti‑proliferation effect of metformin on various solid tumors; however, further and more detailed exploration into its molecular mechanism remains to be performed. The present study aimed to investigate the effect of metformin on cell viability and its underlying mechanism, in the cultured human skin keratinocyte cell line, HaCaT. In addition, it aimed to clarify the role of the microRNA-21(miR-21)/phosphatase and tensin homolog (PTEN)/AKT serine/threonine kinase 1 (Akt) signaling pathway, which has been hypothesized to be involved in the molecular mechanism of this drug. Cell Counting Kit‑8 assays were used to assess the impact of metformin on cell viability; reverse transcription‑quantitative polymerase chain reaction was used to quantify the expression of miR‑21; western blotting was used to monitor the expression level of PTEN and Akt proteins. In addition, miR‑21 expression levels were artificially manipulated in HaCaT cells using a miR‑21 inhibitor in order to observe the subsequent expression changes of miR‑21 targets and alterations in cell viability. The results indicated that metformin suppressed HaCaT cell growth in a dose‑ and time‑dependent manner (P<0.05). Metformin treatment downregulated miR‑21 expression (t=‑8.903, P<0.05). Following transfection with the miR‑21 inhibitor, HaCaT cell growth was significantly slower than in the control groups (P<0.05). In addition, reduced miR‑21 levels results in significantly increased PTEN protein expression levels and reduced Akt protein expression levels compared with control (P<0.05). Metformin was, therefore, concluded to inhibit HaCaT cell growth in a time‑and dose‑dependent manner, and the miR‑21/PTEN/Akt signaling pathway may serve a crucial role in the molecular mechanism of metformin's effect on HaCaT cells. Therefore the present study presents an advanced insight into the potential inhibitory effect of metformin on tumor cells.
Insights
Metformin inhibits human skin keratinocyte (HaCaT) cell growth by downregulating microRNA-21 (miR-21). This mechanism involves increased PTEN and decreased Akt protein levels, suggesting metformin
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Metformin exhibits preclinical anti-proliferative effects on solid tumors.
- The precise molecular mechanisms underlying metformin's anti-tumor activity require further elucidation.
- The microRNA-21 (miR-21)/phosphatase and tensin homolog (PTEN)/AKT serine/threonine kinase 1 (Akt) pathway is a potential mediator of metformin's effects.
Purpose of the Study:
- To investigate metformin's impact on HaCaT cell viability.
- To explore the role of the miR-21/PTEN/Akt signaling pathway in metformin's mechanism of action.
- To determine if modulating miR-21 affects metformin's anti-proliferative effects.
Main Methods:
- Cell Counting Kit-8 assays for cell viability assessment.
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for miR-21 expression analysis.
- Western blotting to quantify PTEN and Akt protein levels.
- Transfection with a miR-21 inhibitor to manipulate miR-21 levels.
Main Results:
- Metformin suppressed HaCaT cell growth in a dose- and time-dependent manner.
- Metformin treatment led to a significant downregulation of miR-21 expression.
- Inhibition of miR-21 significantly reduced HaCaT cell growth.
- Reduced miR-21 levels correlated with increased PTEN and decreased Akt protein expression.
Conclusions:
- Metformin effectively inhibits HaCaT cell proliferation.
- The miR-21/PTEN/Akt signaling pathway plays a significant role in metformin's anti-proliferative mechanism.
- These findings offer insights into metformin's potential as an anti-cancer agent.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway

